Journal article
Intravenous Immune Globulin to Prevent Heparin-Induced Thrombocytopenia
Abstract
Anti–platelet factor 4–heparin antibodies present a major risk of heparin-induced thrombocytopenia (HIT). The use of intravenous immune globulin neutralized large amounts of these antibodies in a p...
Authors
Warkentin TE; Climans TH; Morin P-A
Journal
The New England Journal of Medicine, Vol. 378, No. 19, pp. 1845–1848
Publisher
Massachusetts Medical Society
Publication Date
May 10, 2018
DOI
10.1056/nejmc1801799
ISSN
0028-4793